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 Neonatal tetanus is a rare disease in developed countries, but remains common in 
developing countries. Pregnant women immigrating to Taiwan from developing coun-
tries may carry a risk of neonatal tetanus to the child, because of inadequate tetanus 
toxoid immunization and inappropriate postnatal cord care. Many young pediatricians 
in Taiwan are unfamiliar with this disease. Herein, we describe the clinical course of a 
newborn with neonatal tetanus, who was admitted with complaints of difficult feed-
ing and muscle rigidity. After mechanical ventilation for 58 days and a prolonged hos-
pital stay, the infant was discharged in good condition. It is important to maintain a 
high index of suspicion for neonatal sepsis when infants present with seizure-like 
symptoms, in order to allow its early diagnosis and appropriate treatment. 
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1.  Introduction 
 Neonatal tetanus has previously been a major 
cause of neonatal death. However, the advent of 
tetanus toxoid vaccination and routine aseptic de-
livery means that it has now become a rare disease 
in developed countries. There have been no reported 
cases of neonatal tetanus in Taiwan for many years. 
However, it remains an important cause of neona-
tal death in developing countries. 
 An increasing number of immigrants are moving 
to Taiwan from Southeast Asia and China, where in-
dividuals are not always routinely vaccinated against 
tetanus. Immigrant women may not have received 
tetanus toxoid vaccination during childhood and 
therefore cannot transfer tetanus antibodies to their 
developing fetus during pregnancy. There is thus a 
risk of the neonate developing tetanus if the sub-
sequent delivery and umbilical cord care are not 
aseptic. 
 We report on a pregnant immigrant mother from 
Vietnam who delivered at home. The baby exhibited 
symptoms of neonatal tetanus at 3 days of age, 
was admitted to hospital, and was subsequently 
discharged after more than 2 months of hospitali-
zation. This case should remind physicians of the 
symptoms of neonatal tetanus, and alert them to 
the possibility of similar presentations occurring in 
the future. 
2.  Case Report 
 A full-term female infant (birth weight 2500 g) born 
to a Vietnamese mother at home was admitted at 
5 days of age. The delivery was performed with the 
assistance of the woman’s mother, who performed 
non-aseptic cord cutting using scissors. The first 
2 days of the infant’s life were uneventful. How-
ever, 2 days prior to admission, the infant exhibited 
poor feeding and muscle rigidity. Fever and irrita-
bility developed on the following day. Sei zure and 
lip cyanosis were observed on the morning of 
admission. 
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 Meningitis was initially suspected upon admis-
sion. The patient was transferred to the hospital 
pediatric intensive care unit where trismus, neck 
stiffness, four-limb spasticity and stridor were ob-
served (Figure 1). A foul odor emanated from around 
the umbilicus, and erythema was observed in the 
umbilicus (Figure 2). Body temperature was 40ºC. 
 Neonatal tetanus was highly suspected on the 
basis of the clinical manifestations and case history. 
Diazepam followed by phenobarbital was prescribed 
for persistent spasticity. However, the spasticity per-
sisted and rocuronium was administered, after 
which the spasticity subsided rapidly. 
 At admission, the white blood cell count was 22.8  × 
10 9 /L. Biochemical analysis of plasma revealed the 
following: Ca++, 2.37 mmol/L; Mg++, 1.3 mmol/L; Na+, 
146 mmol/L; glucose, 10.3 mmol/L; blood urea nitro-
gen, 8.2 mmol/L; creatinine, 27 μmol/L; C-reactive 
protein  < 3.8 nmol/L. Cerebrospinal fluid was clear 
with a white blood cell count, 0.039  × 10 9 /L; poly-
morphonuclear leukocytes, 30%; lymphocytes, 70%; 
glucose, 4.4 mmol/L; protein, 87 mg/dL; and normal 
Gram staining. Arterial blood gas under spontane-
ous respiration was: pH, 7.25; pCO 2 , 31 mmHg; pO 2 , 
132 mmHg; HCO 3 , 14 mmol/L. 
 Brain sonography at admission revealed no abnor-
malities. Tetanus immunoglobulin (500 IU) was admin-
istered intramuscularly after admission, in addition 
to aqueous penicillin and cefotaxime. Endotracheal 
intubation was performed to control spasticity and 
unstable peripheral O2 saturation . The patient’s body 
temperature was 38 ° C on the day after admission, 
and no fever was detected from the third day of hos-
pitalization. Cerebrospinal fluid and blood cultures 
were negative, while umbilicus culture was posi-
tive for  Staphylococcus aureus . Aqueous penicillin 
was given for 14 days. There was no spasticity at 
rest after rocuronium treatment, but mild spastic-
ity upon minor external stimuli was still apparent. 
The patient exhibited normal chest x-ray findings 
on admission, but lung collapse at the right upper 
lobe with unstable peripheral O2 saturation devel-
oped on day 8 of hospitalization (Figure 3). Complete 
resolution of lung collapse was noted on day 12 of 
A B
 Figure 3 (A) Chest X-ray of the baby was normal at admission. (B) Chest X-ray demonstrating right upper 
lung collapse on day 8 of hospitalization. 
 Figure 2 Erythema and discharge in the umbilicus 
was found at admission. 
 Figure 1 Significant spasticity of the four extremi-
ties was shown in the baby before administration 
of neuromuscular agent. 
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hospitalization. Phenobarbital and diazepam were 
discontinued on days 12 and 15 of hospitalization, 
respectively, following improvement of spasticity. 
Rocuronium discontinuation was unsuccessfully at-
tempted on days 19, 29, 35, 43 and 50 of hospitali-
zation. On each occasion, mild cyanosis became 
apparent within several hours of discontinuation. 
Rocuronium treatment was successfully discontin-
ued on day 57 of hospitalization. The patient was 
extubated on day 58 and subsequently discharged 
73 days after admission. Satisfactory oral feeding 
was evident after extubation. The patient was lost 
to follow-up after discharge. 
3.  Discussion 
 Approximately 515,000 neonatal deaths were attrib-
uted to tetanus worldwide in 1993.1 The World Health 
Organization 2 aimed to achieve worldwide neonatal 
tetanus elimination by 2005, which was defined as 
the reduction of neonatal tetanus cases to less than 
1 case per 1,000 live births in every district of every 
country. In 2000, neonatal tetanus was still not elim-
inated in 57 countries, including Vietnam and China. 2 
 The incidence of neonatal tetanus in Taiwan 
was high in the 1950s, with a mortality of around 
3 per 1,000 live births. 3 However, neonatal tetanus 
is a rare disease in developed countries because of 
mass vaccination, aseptic delivery and hygienic cord 
care. Neonatal tetanus has also become rare in 
Taiwan in recent years, with only few cases reported 
in 1993, 1994 and 2001. 4 
 The symptoms of tetanus leading to its clinical 
diagnosis include an inability of the newborn to suckle 
at and shortly after birth, an inability to suckle be-
tween 3 and 10 days of age, spasms, stiffness, con-
vulsions and death. These clinical manifestations 
may be confused with seizure. The major differen-
tiating factor is that unlike seizure, consciousness is 
maintained with tetanus. Meningitis, hypocalcemia 
and hypoglycemia may also produce similar clinical 
manifestations. Neonatal tetanus cannot be con-
firmed by laboratory studies. However, signs of um-
bilical infection such as discharge, erythema, swelling, 
tenderness and local heat have been noted in 70% 
of patients with tetanus in a study by Lee and Lin. 3 
The first symptoms of neonatal tetanus have been 
reported to be trismus (85 of the 91 cases, 93%), dif-
ficult feeding (76 of the 91 cases, 84%), risus sardoni-
cus (73 of the 91 cases, 80%) and neck stiffness (61 
of the 91 cases, 67%). 3 The reported incubation 
time is between 4 and 19 days. 3 Treatment for ne-
onatal tetanus includes tetanus immunoglobulin, 
wound care (including debridement if indicated), 
benzodiazepine administration, neuromuscular block-
age, mechanical ventilation, aqueous penicillin and 
placement in a dim, quiet environment. In the present 
case, 500 IU tetanus immunoglobulin was admin-
istered intramuscularly; however, doses of 3000−
6000 IU have been suggested previously. 5 Lee and 
Lin 3 found that early administration of tetanus im-
munoglobulin did not appear to improve the prog-
nosis. Indeed, mortality was 72.5% (58 of 80 cases) 
when tetanus immunoglobulin was given within 3 
days after onset; this was higher than the overall av-
erage mortality of 69%. 3 However, a study by Blake 
and colleagues 5  suggested that tetanus immunoglob-
ulin could lower the case-fatality ratio significantly. 
Our patient exhibited symptom onset at 3 days of 
age and was admitted to hospital at 5 days. Rocuro-
nium was administered for 57 days and mechanical 
ventilation was applied for 58 days. These long du-
rations may have been necessary because of the 
early onset and 2-day treatment delay in this case. 
 The mortality due to neonatal sepsis declined in 
the 1970s, as mechanical ventilation and neuromus-
cular agents became available for its treatment. In 
the United States, all five infants with neonatal tet-
anus managed with neuromuscular blocking agents 
and positive pressure ventilation between 1975 and 
1978 survived, with a mean mechanical ventilation 
time of 34 days (range: 25−45 days). 6 Similar find-
ings were reported from Mexico, 7 where the over-
all mortality of neonatal tetanus in 1980−1990 was 
12.9%, which was considerably lower than the mor-
tality of 25% in 1970−1980. The authors attributed 
this improvement in mortality to mechanical ven-
tilation and intensive care. 7 
 The mortalities associated with neonatal teta-
nus at several medical centers in Taiwan were re-
ported to be 69% (63 of the 91 cases) between 1953 
and 1964, 34% (23 of the 67 cases) between 1970 and 
1980, and 83% (5 of the 6 cases) between 1971 and 
1990. 3,8,9 Shorter incubation times were associated 
with higher mortalities. All patients with symptom 
onset before 5 days of age died, most within 1 week 
of onset. 3,9 The predominant cause of death was 
apnea (35 of the 53 cases, 66%). 2 Bronchopneu-
monia, presumably resulting from aspiration, is a 
common complication and another frequent cause 
of death. Our patient had a collapsed right upper 
lung, which may have been the result of aspiration, 
but this condition resolved rapidly. 
 The minimum tetanus antibody concentration 
conferring protection against disease or death 
in humans has not been established. Tetanus anti-
body concentrations in the conventionally accepted 
protective range are  > 0.01 IU/mL. The antibody con-
centration decreases with time. If full tetanus tox-
oid immunization is initiated from infancy, the 
protective antibody level is maintained in 96% of 6 
year-olds, 90% of 7−9-year-olds, and 80% of 10−16-
year-olds. 10 The transplacental transfer of tetanus 
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antibodies from mother to fetus results in a dilutional 
effect, as indicated by the finding that most new-
borns had lower antibody levels than their mother 
(the newborn-to-mother ratio was 0.59). 11 It has 
been reported that transfer of protective antibod-
ies to newborns can occur if a mother has an anti-
body level  > 1.28 IU/mL. 12 However, some newborns 
still develop tetanus even when levels are 4−13 
times higher than the protective level. 13 
 Despite being rare in developed countries, neo-
natal tetanus remains common in some developing 
countries. The increase in international marriages 
in Taiwan means that some diseases common in 
other countries should be considered in differen-
tial diagnoses, to avoid delays or misdiagnosis. 
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